- Press Release Distribution

DNA aptamer drug sensors can instantly detect cocaine, heroin and fentanyl – even when combined with other drugs

( Researchers from North Carolina State University have developed a new generation of high-performance DNA aptamers and highly accurate drug sensors for cocaine and other opioids. The sensors are drug specific and can detect trace amounts of fentanyl, heroin, and cocaine – even when these drugs are mixed with other drugs or with cutting agents and adulterants such as caffeine, sugar, or procaine. The sensors could have far-reaching benefits for health care workers and law enforcement agencies.

“This work can provide needed updates to currently used tests, both in health care and law enforcement settings,” says Yi Xiao, associate professor of chemistry at NC State and corresponding author of two studies describing the work.

“For example, drug field testing currently used by law enforcement still relies on chemical tests developed a century ago that are poorly specific, which means they react to compounds that may not be the drug they’re looking for,” Xiao says.

“And the existing aptamer test for cocaine isn’t sensitive and specific enough to detect clinically relevant amounts of the drug in biological samples, like blood. The sensors we developed can detect cocaine in blood at nanomolar, rather than micromolar, levels, which represents a 1,000-fold improvement in sensitivity.”

In a pair of studies appearing in the Journal of the American Chemical Society (JACS) and JACS Au, Xiao led a team that developed aptamer-based sensors for cocaine, heroin, codeine, fentanyl and other illicit drugs.

An aptamer is a short single strand of DNA or RNA that will bind to a specific molecule with high affinity, meaning that it won’t bind to molecules other than the one of interest. The researchers begin the search by adding the molecule of interest – cocaine, for example – to a mixture of hundreds of trillions of randomized DNA sequences. Then they see which aptamer binds to the molecule.

“We refer to the process as ‘bio-panning,’ since it is a lot like sifting through river sediment to find gold,” says Obtin Alkhamis, NC State graduate student and co-author of both papers. “Once we separate the target-bound strands from non-bound strands, we rigorously test that aptamer against other interfering compounds to ensure that it is specific only to the compound of interest.”

The researchers then tested the compound-specific aptamers against pharmaceutical mixtures, tablets and blood, to determine whether they could identify certain drugs in the samples.

Xiao’s team used the cocaine aptamer to detect cocaine in blood serum at levels of 10 nanomolar (equivalent to 30 nanograms per milliliter or 30 parts-per-billion), a 1,000-fold improvement over the best prior aptamer test which can only detect 10 micromolar cocaine in 50% serum.

Additionally, collaborators at the University of California Santa Barbara were able to incorporate the aptamer into an electrode that could measure drug concentration in situ in the blood (in a vein) of rats in real time every 10 seconds over a two-hour time period. This is the first study able to measure the pharmacology of a drug of abuse with time resolution measured in seconds.

The opioid-specific aptamers were incorporated into colorimetric assays that can specifically detect opioids like heroin and oxycodone in solution at levels as low as 0.5 micromolar (μM). A colorimetric assay is a test that changes color when the compound of interest is detected. These assays were also able to detect opioids in complex chemical matrices within seconds – including pharmaceutical tablets and drug mixtures.

For comparison, the “Marquis test,” a standard test used by law enforcement officials and forensic laboratories, could not detect opioids in chemical mixtures.

The researchers believe that these aptamer sensors have useful applications for health and public safety.

“The aptamers can be mass produced, have a long shelf life and are easily chemically modified, which means they can be utilized for any type of sensor you develop,” Xiao says. “So they could be incorporated into testing strips for officers in the field, for use at home or for human patients in a physician’s office.”

“Since they detect drugs at clinically relevant levels, you could potentially do a blood drop test in the ER to immediately determine what a patient may have taken, without a full blood draw and lab testing,” Alkhamis says. “The possible uses are really exciting.”

The work was supported by the National Institute of Justice (awards 2019-DU-BX-0024 and 2022-GG-04440-RESS), the National Science Foundation (grant CHE-2135005), and the National Institutes of Health (grant R01DA051100). Nicole Emmons, Yuting Wang, Kevin Honeywell, Kevin Plaxco and Tod Kippin, all from the University of California Santa Barbara, contributed to the development of the electrochemical aptamer-based sensor for in vivo cocaine testing. NC State graduate students Juan Canoura, Yuyang Wu, Matthew Venzke and Phuong Ly also contributed to the opioid work.


Note to editors: Abstracts follow.

“High-Affinity Aptamers for In Vitro and In Vivo Cocaine Sensing”

DOI: 10.1021/jacs.3c11350

Authors: Obtin Alkhamis, Juan Canoura, Yuyang Wu, Yi Xiao, North Carolina State University; Nicole A. Emmons, Yuting Wang, Kevin M. Honeywell, Kevin W. Plaxco, Tod E. Kippin, University of California Santa Barbara
Published: Jan. 30, 2024 in the Journal of the American Chemical Society

The ability to quantify cocaine in biological fluids is crucial for both the diagnosis of intoxication and overdose in the clinic as well as investigation of the drug’s pharmacological and toxicological effects in the laboratory. To this end, we have performed high-stringency in vitro selection to generate DNA aptamers that bind cocaine with nanomolar affinity and clinically relevant specificity, thus representing a dramatic improvement over the current-generation, micromolar-affinity, low-specificity cocaine aptamers. Using these novel aptamers, we then developed two sensors for cocaine detection. The first, an in vitro fluorescent sensor, successfully detects cocaine at clinically relevant levels in 50% human serum without responding significantly to other drugs of abuse, endogenous substances, or a diverse range of therapeutic agents. The second, an electrochemical aptamer-based sensor, supports the real-time, seconds-resolved measurement of cocaine concentrations in vivo in the circulation of live animals. We believe the aptamers and sensors developed here could prove valuable for both point-of-care and on-site clinical cocaine detection as well as fundamental studies of cocaine neuropharmacology.

“Developing Aptamer-Based Colorimetric Opioid Tests”

DOI: 10.1021/jacsau.3c00801

Authors: Juan Canoura, Obtin Alkhamis, Matthew Venzke, Phuong T. Ly and Yi Xiao, North Carolina State University
Published: March 1, 2024 in the JACS Au

Opioids collectively cause over 80,000 deaths in the United States annually. The ability to rapidly identify these compounds in seized drug samples on-site will be essential for curtailing trafficking and distribution. Chemical reagent-based tests are fast and simple but also notorious for giving false results due to poor specificity, whereas portable Raman spectrometers have excellent selectivity but often face interference challenges with impure drug samples. In this work, we develop on-site sensors for morphine and structurally related opioid compounds based on in vitro-selected oligonucleotide affinity reagents known as aptamers. We employ a parallel-and-serial selection strategy to isolate aptamers that recognize heroin, morphine, codeine, hydrocodone, and hydromorphone, along with a toggle-selection approach to isolate aptamers that bind oxycodone and oxymorphone. We then utilize a new high-throughput sequencing-based approach to examine aptamer growth patterns over the course of selection, and a high-throughput exonuclease-based screening assay to identify optimal aptamer candidates. Finally, we use two high-performance aptamers with KD of ~1 µM to develop colorimetric dye-displacement assays that can specifically detect opioids like heroin and oxycodone at concentrations as low as 0.5 µM with a linear range of 0–16 µM. Importantly, our assays can detect opioids in complex chemical matrices, including pharmaceutical tablets and drug mixtures; in contrast, the conventional Marquis test completely failed in this context. These aptamer-based colorimetric assays enable naked-eye identification of specific opioids within seconds and will play an important role in combatting opioid abuse.



New project will use next-gen at-home rapid test to track COVID-19, RSV, and flu

The City University of New York (CUNY) Institute for Implementation Science in Population Health (ISPH) and the CUNY Graduate School of Public Health and Health Policy (CUNY SPH), in collaboration with Pfizer, are initiating a critical two-year prospective epidemiologic study in the spring of 2024 to track acute respiratory infections across the United States. Project PROTECTS (Prospective Respiratory Outcomes from Tracking and Evaluating Community-based TeSting) builds on the pivotal CHASING COVID Cohort Study, which has monitored SARS-CoV-2 infection rates and associated risk factors through questionnaires and at-home serological testing since March 2020. The cohort's ...

SRI relaunches the PARC Forum event series as it celebrates the first anniversary of acquiring the storied Palo Alto Research Center

Menlo Park, CA: SRI announced today the relaunch of PARC Forum, an event and program series that brings together some of the world’s leading thinkers for thought-provoking conversations at the intersection of technology and society.  The first PARC Forum event marks the first anniversary of SRI’s acquisition through a donation from Xerox of the Palo Alto Research Center (PARC ). The acquisition brought together two iconic Silicon Valley organizations that have created and delivered technologies, services, and ideas that have had a profound impact on every one of our lives.     SRI’s ...

An inside look at Beech tree disease

An inside look at Beech tree disease
Beech trees provide food for animals, timber for wood products, and sustenance for beech drop plants, but they are under threat from Beech Leaf Disease (BLD). The disease, first documented in 2012 in the Midwest, is associated with the nematode Litylenchus crenatae mccannii and is spreading rapidly throughout the central and northeast regions of North America. A team of scientists led by Craig Brodersen, professor of plant physiological ecology, and Leila Fletcher, postdoctoral associate, at the Yale School of the Environment has uncovered ...

New AI model draws treasure maps to diagnose disease

New AI model draws treasure maps to diagnose disease
Medical diagnostics expert, doctor’s assistant, and cartographer are all fair titles for an artificial intelligence model developed by researchers at the Beckman Institute for Advanced Science and Technology. Their new model accurately identifies tumors and diseases in medical images and is programmed to explain each diagnosis with a visual map. The tool’s unique transparency allows doctors to easily follow its line of reasoning, double-check for accuracy, and explain the results to patients. "The idea is to help catch cancer and disease in its earliest stages — like an X on ...

Breastfeeding after COVID-19 booster can give babies antibodies

Lactating mothers who get the COVID-19 booster pass along the antibodies to their children via their breast milk – and potentially protect babies too young to receive the vaccine, a study from the University of Florida Institute of Food and Agricultural Sciences (UF/IFAS) and the UF College of Medicine found. The study is the third in a series that looks at antibody protection being transferred via breast milk from mothers who received their first two COVID-19 vaccinations and, now, the booster shot. The second publication reported the same antibody transfer via breast milk. “We think that breast milk may play an important ...

Researchers closing in on genetic treatments for hereditary lung disease, vision loss

Researchers closing in on genetic treatments for hereditary lung disease, vision loss
PORTLAND, Ore. – Researchers who work with tiny drug carriers known as lipid nanoparticles have developed a new type of material capable of reaching the lungs and the eyes, an important step toward genetic therapy for hereditary conditions like cystic fibrosis and inherited vision loss. Findings of the study led by Gaurav Sahay and Yulia Eygeris of the Oregon State University College of Pharmacy and Renee Ryals of Oregon Health & Science University were published today in the Proceedings of the National Academy of Sciences. Unlike other types of lipid nanoparticles that tend to accumulate in the liver, the ones in this study, ...

COVID-19 associated with increased risk for autoimmune inflammatory rheumatic diseases up to a year after infection

Below please find summaries of new articles that will be published in the next issue of Annals of Internal Medicine. The summaries are not intended to substitute for the full articles as a source of information. This information is under strict embargo and by taking it into possession, media representatives are committing to the terms of the embargo not only on their own behalf, but also on behalf of the organization they represent.    ----------------------------    1. COVID-19 associated with increased risk for autoimmune inflammatory rheumatic diseases up to a year after infection Vaccination showed some protection against AIRDs, depending on severity ...

UC Irvine receives $15 million NSF grant for integrative movement research

Irvine, Calif. March 4, 2024 — The National Science Foundation has granted $15 million to the Integrative Movement Sciences Institute at the University of California, Irvine. This six-year funding, part of the NSF’s Biology Integration Institutes program, will support groundbreaking research led by Monica Daley, professor of ecology & evolutionary biology at the UCI School of Biological Sciences. The research funded by this grant aims to understand the intricate mechanics of muscle control during rapid, unsteady movements in complex environments. Muscle ...

University of Houston engineer Metin Akay featured in study highlighting 50 scientists' contributions to biomedical engineering advancements

University of Houston engineer Metin Akay featured in study highlighting 50 scientists contributions to biomedical engineering advancements
Metin Akay, founding chair of the Biomedical Engineering Department at the University of Houston and John S. Dunn Professor, is one of 50 top scientists from 34 elite universities to publish a roadmap for groundbreaking research to transform the landscape of medicine in the coming decade.  Published on behalf of the Institute of Electrical and Electronics Engineers (IEEE), the world’s largest technical professional organization dedicated to advancing technology for humanity and the IEEE Engineering in Medicine and Biology Society (IEEE EMBS), the paper focus ...

JWST captures the end of planet formation

JWST captures the end of planet formation
March 4, 2024, Mountain View, CA – The James Webb Space Telescope (JWST) is helping scientists uncover how planets form by advancing understanding of their birthplaces and the circumstellar disks surrounding young stars, in a paper published in the Astronomical Journal, a team of scientists led by Naman Bajaj of the University of Arizona and including Dr. Uma Gorti at the SETI Institute, image for the first time, winds from an old planet-forming disk (still very young relative to the Sun) which is actively dispersing its gas ...


UK/Portuguese study strongly suggests antibiotic-resistant “superbugs” are being passed from cats and dogs to their owners

Researchers study effects of solvation and ion valency on metallopolymers

Physicists solve puzzle about ancient galaxy found by Webb telescope

Clear guidelines needed for synthetic data to ensure transparency, accountability and fairness study says

Report finds significant gender and racial inequities in the educational measurement profession

University of Houston and Scotland’s Heriot-Watt University forge strategic energy alliance

Rice team demonstrates miniature brain stimulator in humans

Jennifer Stinson receives prestigious Barer-Flood Prize in health services research

First insights into the genetic bottleneck characterizing early sheep husbandry in the Neolithic period

Theories that explain the crisis in democracy are inadequate for Latin America, experts say

Starving cells hijack protein transport stations

Where have all the right whales gone?

Researchers find no link between COVID-19 virus and development of asthma in children

Cell’s ‘garbage disposal’ may have another role: helping neurons near skin sense the environment

Study reveals potential to reverse lung fibrosis using the body’s own healing technique

International team co-led by a BSC researcher discovers more than 50 new deep-sea species in one of the most unexplored areas of the planet

Cleveland Innovation District partners exceeding many targets set by state and JobsOhio

A third of women experience migraines associated with menstruation, most commonly when premenopausal

MD Anderson Research Highlights for April 12, 2024

Soft Robotics appoints new Deputy Editor-in-Chief, Barbara Mazzolai, PhD

Wiley releases Mass Spectra of Designer Drugs 2024 to accelerate forensics analysis of fentanyls, cannabinoids, and more

Freestanding emergency departments are popular, but do they function as intended?

University of Cincinnati experts present at national neurology conference

Bonobos are more aggressive than previously thought

How seaweed became multicellular

Melanomas resist drugs by ‘breaking’ genes

Africa’s iconic flamingos threatened by rising lake levels, study shows

Vaccination timeliness among US children ages 0-19 months

Changes in permanent contraception procedures among young adults following the Dobbs decision

Semaglutide vs endoscopic sleeve gastroplasty for weight loss

[] DNA aptamer drug sensors can instantly detect cocaine, heroin and fentanyl – even when combined with other drugs